Andere Sprachen Orexo AB OTC Markets

Aktien

ORXOY

US68616W1027

ORXOY

Markt geschlossen - OTC Markets Andere Börsenplätze 16:00:30 06.05.2024			% 5 Tage	% 1. Jan.
1,65 ^USD	+17,86 %		-.--%	+9,27 %

08.05.	Transcript : Orexo AB, Q1 2024 Earnings Call, May 08, 2024
17.04.	Orexo verlängert den Patentschutz für sein nasales Epinephrin-Pulver OX640 in den USA	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Transcript : Orexo AB, Q1 2024 Earnings Call, May 08, 2024	08.05.
Orexo Extends Patent Protection for Its Nasal Epinephrine Powder Product OX640 in the US	17.04.
Sweden's Orexo Set for Early Redemption of Bonds Due 2025	02.04.
Orexo AB Announces Board Resignations	22.03.
Orexo Issues SEK500 Million Social Bonds, Closes Tender Offer	14.03.
Orexo Plans SEK500 Million New Social Bond Issuance, Tender Offer	08.03.
Orexo, Swedish Orphan Biovitrum to Further Explore AmorphOX Combination	12.02.
Orexo AB (Publ.) and Swedish Orphan Biovitrum AB (publ.) Agrees to Advance Feasibility Study with Amorphox	12.02.
Transcript : Orexo AB, 2023 Earnings Call, Feb 08, 2024	08.02.
Orexo AB Reports Earnings Results for the Full Year Ended December 31, 2023	08.02.
US FDA Approves New Drug Application for Orexo's Opioid Overdose Rescue Medication	28.11.
Orexo AB Announces FDA Acceptance of New Drug Application Filing for OX124	28.11.
Transcript : Orexo AB, Q3 2023 Earnings Call, Nov 02, 2023	02.11.
Orexo AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	02.11.
Orexo AB Announces Changes in the Board of Directors	27.10.23
Orexo AB Announces Nomination Committee Appointments	26.10.23
Orexo AB Announces Resignation of Robin Evers as A Board Member	26.10.23
Orexo's Opioid Use Disorder Drug Study Shows Unexpectedly High Treatment Response Rates	11.10.23
Orexo AB Announces Data from the MODIA Study Evaluating Impact on Use of Illicit Opioids	11.10.23
Orexo AB Announces Henrik Kjær Hansen Will Resign from the Board of Directors	02.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Orexo AB OTC Markets

Aktien

ORXOY

US68616W1027

ORXOY

Andere Sprachen

Filter